Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Pharmacol Ther. 2014 Apr;95(4):403-12. doi: 10.1038/clpt.2014.5. Epub 2014 Jan 13.

Race and ethnicity in cancer therapy: what have we learned?

Author information

  • 11] The Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA [2] Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  • 21] The Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA [2] Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

Abstract

Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will be imperative that we understand the relative contributions of each factor so that we may apply this knowledge in choosing the best treatment for each individual, regardless of his or her racial or ethnic heritage.

PMID:
24419564
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk